1. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. Issue 2 (28th January 2015) Authors: Togashi, Yosuke; Kogita, Akihiro; Sakamoto, Hiroki; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Kitano, Masayuki; Okuno, Kiyotaka; Kudo, Masatoshi; Nishio, Kazuto Journal: Cancer letters Issue: Volume 356:Issue 2(2015)Part B Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. Issue 2 (28th January 2015) Authors: Togashi, Yosuke; Kogita, Akihiro; Sakamoto, Hiroki; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Kitano, Masayuki; Okuno, Kiyotaka; Kudo, Masatoshi; Nishio, Kazuto Journal: Cancer letters Issue: Volume 356:Issue 2(2015)Part B Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal. Issue 1 (April 2015) Authors: Togashi, Yosuke; Hayashi, Hidetoshi; Okamoto, Kunio; Fumita, Soichi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nakagawa, Kazuhiko; Nishio, Kazuto Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal. Issue 1 (April 2015) Authors: Togashi, Yosuke; Hayashi, Hidetoshi; Okamoto, Kunio; Fumita, Soichi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nakagawa, Kazuhiko; Nishio, Kazuto Journal: Lung cancer Issue: Volume 88:Issue 1(2015:Apr.) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinicopathological and genetic differences between low‐grade and high‐grade colorectal mucinous adenocarcinomas. Issue 24 (21st October 2015) Authors: Yoshioka, Yasumasa; Togashi, Yosuke; Chikugo, Takaaki; Kogita, Akihiro; Taguri, Masataka; Terashima, Masato; Mizukami, Takuro; Hayashi, Hidetoshi; Sakai, Kazuko; de Velasco, Marco A.; Tomida, Shuta; Fujita, Yoshihiko; Tokoro, Tadao; Ito, Akihiko; Okuno, Kiyotaka; Nishio, Kazuto Journal: Cancer Issue: Volume 121:Issue 24(2015) Page Start: 4359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Issue 11 (November 2016) Authors: Hibi, Masaaki; Kaneda, Hiroyasu; Tanizaki, Junko; Sakai, Kazuko; Togashi, Yosuke; Terashima, Masato; De Velasco, Marco Antonio; Fujita, Yoshihiko; Banno, Eri; Nakamura, Yu; Takeda, Masayuki; Ito, Akihiko; Mitsudomi, Tetsuya; Nakagawa, Kazuhiko; Okamoto, Isamu; Nishio, Kazuto Journal: Cancer science Issue: Volume 107:Issue 11(2016) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non–small-cell Lung Cancer with a T790M Mutation. Issue 1 (January 2015) Authors: Togashi, Yosuke; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nakagawa, Kazuhiko; Nishio, Kazuto Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non–small-cell Lung Cancer with a T790M Mutation. Issue 1 (January 2015) Authors: Togashi, Yosuke; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nakagawa, Kazuhiko; Nishio, Kazuto Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor. Issue 3 (December 2015) Authors: Togashi, Yosuke; Mizuuchi, Hiroshi; Tomida, Shuta; Terashima, Masato; Hayashi, Hidetoshi; Nishio, Kazuto; Mitsudomi, Tetsuya Journal: Lung cancer Issue: Volume 90:Issue 3(2015:Dec.) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?. Issue 8 (14th July 2016) Authors: Banno, Eri; Togashi, Yosuke; Nakamura, Yu; Chiba, Masato; Kobayashi, Yoshihisa; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Mitsudomi, Tetsuya; Nishio, Kazuto Journal: Cancer science Issue: Volume 107:Issue 8(2016) Page Start: 1134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗